Samsung Biologics
207940.KS
$528.33
Share price
-0.27%
Change (1 day)
-11.38%
Change (1 year)
Categories
Samsung Biologics (207940.KS) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $4.84 B
According to Samsung Biologics 's latest financial reports the company's total liabilities are $4.84 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Samsung Biologics - Total liabilities on balance sheet (from 2016 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $4.80 B | -20.25% |
| 2022-12-31 | $6.02 B | 140.68% |
| 2021-12-31 | $2.50 B | 49% |
| 2020-12-31 | $1.68 B | 24.77% |
| 2019-12-31 | $1.34 B | -17.63% |
| 2018-12-31 | $1.63 B | -45.65% |
| 2017-12-31 | $3.00 B | 5.08% |
| 2016-12-31 | $2.86 B | 5.62% |
| 2015-12-31 | $2.71 B | 309.46% |
| 2014-12-31 | $0.66 B |